A Study of LY2495655 in Older Participants Undergoing Elective Total Hip Replacement

NCT01369511 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Muscular Atrophy

Interventions

DRUG: LY2495655
DRUG: Placebo

Sponsor

Eli Lilly and Company